Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us

Media

  • Highlights
  • Press Releases
  • Events
  • News
  • Articles
  • Posters
  • Immunomic Therapeutics Offers Travel Fund for Clinical Trial Patients

    Press Releases
    October 11, 2017 07:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is proud to announce a travel fund for patients enrolled
    Read more
  • 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 2017

    Events Past Events
    The 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology will be held November 16-19, 2017 in San Francisco, CA.  This year's meeting will highlight a number of the
    Read more
  • Congress of Neurological Surgeons Annual Meeting 2017

    Events Past Events
    The Congress Of Neurological Surgeons is hosting their Annual Meeting from 7 Oct to 11 Oct in Boston, MA. The CNS Annual Meeting is the premier forum for learning about
    Read more
  • What’s Behind the Fear of Vaccines?

    Articles Blog Featured
    A closer look at the social, cultural and political issues influencing immunization This article was produced for Immunomic Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.
    Read more
  • Immunomic Therapeutics Celebrates National Immunization Awareness Month

    Blog
    August is National Immunization Awareness Month and Rockville, MD based Immunomic Therapeutics is dedicated to raising awareness of the importance of receiving life-saving vaccines. Vaccines are recommended to people of
    Read more
  • Immunomic Therapeutics Welcomes New Oncology Advisor

    Press Releases
    July 31, 2017 07:30 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is pleased to welcome a new oncology advisor, Duke University’s
    Read more
  • ESMO Immuno-Oncology Congress

    Events Past Events
    Geneva, Switzerland - 07 Dec - 10 Dec 2017 Oncologists of today must adapt to rapid changes in practice. The promising results of immunotherapies in oncology are generating increasing interest
    Read more
  • Neo Antigen Summit

    Events Past Events
    The Neoantigen Summit is the dedicated end-to-end industry focused meeting ensuring the supercharging of immunotherapies and cancer vaccines to bring truly individualized therapies to patients in need. Hear the latest
    Read more
  • BioEurope 2017

    Events Past Events
    November 6–8, 2017 CityCube Berlin, Berlin, Germany INITIATE NEW PARTNERSHIPS THROUGH LIFE SCIENCE PARTNERING AT BIO-EUROPE 2017 IN BERLIN! This "must-attend" event is Europe's largest life science partnering conference. BIO-Europe's
    Read more
  • 2017 BioNetworking Event

    Events Past Events
    October 23-October 25, 2017 The Ritz-Carlton, Laguna Niguel, CA Partnering Made Easy - The Deal-Making Event For Life Science Groundbreakers BioNetwork is the essential platform for business development executives across the
    Read more
  • Cancer Immunology and Immunotherapy – NIH

    Events Past Events
    CANCER IMMUNOLOGY AND IMMUNOTHERAPY: From Conception to Delivery Masur and Lipsett Auditorium, Blg 10 National Institutes of Health, Bethesda, MD Sponsored by the Center of Excellence in Immunology, NCI This
    Read more
  • ISV Congress

    Events Past Events
    The ISV Annual Congress is the world’s largest scientific conference in the field of vaccines and covers a broad range of topics related to vaccines and immunotherapies. It will bring
    Read more
1234567891011121314151617181920212223242526
← Previous pageNext page →

Content
  • Pipeline
  • Partnerships
  • Team
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Policies
  • Expanded Access Policy
  • Privacy Policy
Social
  • Facebook
  • X / Twitter
  • Youtube
Telephone

+1.301.968.3501

Address

15010 Broschart Road

Rockville, MD 20850

© 2020 Immunomic Therapeutics, Inc. All Rights Reserved.